Oxaliplatin/fluorouracil ‐based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta‐analysis of randomized controlled trials
ConclusionAdjuvant Oxaliplatin/fluorouracil‐based chemotherapy can improve DFS of patients after NCRT and radical surgery, compared with adjuvant fluorouracil‐based chemotherapy. Data of the longer‐term survival outcome are needed.This article is protected by copyright. All rights reserved.
Source: Colorectal Disease - Category: Gastroenterology Authors: Liying Zhao, Ruoyan Liu, Ze Zhang, Tingting Li, Fengping Li, Hao Liu, Guoxin Li Tags: Systematic Review Source Type: research
More News: Anemia | Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Databases & Libraries | Diarrhoea | Eloxatin | Gastroenterology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Rectal Cancers | Science | Study | Thrombocytopenia | Toxicology